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Due to a typographical error, a CD16^−^ and CD16^+^ were switched in the middle of the third paragraph of page 521. The corrected paragraph appears below.

Differentiation and Migration Analysis after Depletion of CD16^+^ Monocytes.
============================================================================

In some depletion experiments, only the M-DC8^+^ subpopulation of CD14^+^CD16^+^ monocytes was removed. Removal of M-DC8^+^ cells only had no marked effect on the yield or phenotype of reverse-transmigrated cells (unpublished data), but when the depletion scheme eliminated all CD16^+^ monocytes (CD16 depleted), 47 ± 22% (P \< 0.05; four experiments) to 66 ± 13% (P \< 0.005; four experiments) fewer reverse transmigrated cells were recovered from unstimulated and zymosan-stimulated cultures, respectively (Fig. 6 A). These results are in agreement with the CFSE experiments in Fig. 3. Even after thorough depletion of CD16^+^ monocytes, many reverse-transmigrated cells recovered from cultures receiving only the CD16^−^ monocytes expressed CD16 upon reverse transmigration, in contrast to the subendothelial monocyte-derived cells from the same cultures (Fig. 6 B). Thus, these cells appear to upregulate CD16 expression during reverse transmigration. When flow cytometry was conducted to analyze the maturation status of cells in the reverse-transmigrated fraction, the number of HLA-DR^+^CD86^+^ cells was 63 ± 14% (average of three experiments; P \< 0.005) decreased per unit area of endothelial cell surface when blood CD16^+^ monocytes were depleted from the starting population (Fig. 6 C; cells shown in each group were recovered from an equivalent area of endothelial surface). Moreover, the residual DCs recovered after depletion of CD16^+^ monocytes expressed an order of magnitude less CD86 on the cell surface, indicating that these reverse-transmigrated, CD16^−^ monocyte-derived cells were less mature than the reverse-transmigrated cells that develop in cultures that contained CD16^+^ blood monocytes.
